Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025
Q4 FY25 results · Jan–Mar 2025
Advanced Enzyme Technologies reported revenue from operations of ₹167.18 crore (up 5.9% from Q4 FY24) and net profit of ₹26.73 crore (down 10.5% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 167.18 | 157.81 | +5.9% | 169.11 | −1.1% |
| Other income | 8.74 | 9.50 | −7.9% | 7.68 | +13.8% |
| Total income | 175.92 | 167.31 | +5.1% | 176.80 | −0.5% |
| Profit before tax | 43.46 | 39.61 | +9.7% | 53.02 | −18.0% |
| Net profit for the period | 26.73 | 29.87 | −10.5% | 38.88 | −31.2% |
| Attributable to shareholders of the company | 26.48 | 28.31 | −6.5% | 37.65 | −29.7% |
| EPS, basic (₹) | 2.37 | 2.53 | −6.3% | 3.36 | −29.5% |
| Net margin (%) | 16.0 | 18.9 | 23.0 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 87.21 | 92.40 | −5.6% | 100.87 | −13.5% |
| Other income | 4.53 | 3.21 | +41.1% | 1.43 | +217.0% |
| Total income | 91.74 | 95.61 | −4.1% | 102.30 | −10.3% |
| Profit before tax | 15.51 | 10.39 | +49.3% | 20.54 | −24.5% |
| Net profit for the period | 11.05 | 3.14 | +252.3% | 15.18 | −27.2% |
| EPS, basic (₹) | 0.99 | 0.28 | +253.6% | 1.36 | −27.2% |
| Net margin (%) | 12.7 | 3.4 | 15.1 |
Consolidated
- Filed with BSE
- 13 May 2025, 19:19 IST
- Board meeting
- 13 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 May 2025, 19:19 IST
- Board meeting
- 13 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE